1462P Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination: NEMESIA (non-clear metastatic renal cell carcinoma pembrolizumab axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a)

Authors :: M. Stellato
S. Buti
M. Maruzzo
M. Bersanelli
P. Ermacora
B.A. Maiorano
V. Prati
U.F.F. De Giorgi
F. Pierantoni
A. Malgeri
A. Mennitto
A. Cavo
M.G. Vitale
M. Santoni
C. Carella
G. Procopio
E. Verzoni
D. Santini
Source :: Annals of Oncology. 33:S1214-S1215
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools